422
Participants
Start Date
July 25, 2023
Primary Completion Date
April 30, 2025
Study Completion Date
September 30, 2025
GNR-068
GNR-068 was administered subcutaneously at weeks 0 and 4 weeks then every 12 weeks thereafter until week 52.
Stelara®
Stelara® was administered subcutaneously at weeks 0 and 4 weeks then every 12 weeks thereafter until week 28 and then all patients receive GNR-068 45 mg until week 52.
"Limited Liability Company OLLA-MED", Moscow
"Federal State Budgetary Institution Research Institute of Rheumatology named after V.A. Nasonova", Moscow
"Limited Liability Company Firma ORIS", Moscow
"State budgetary healthcare institution of the city of Moscow Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology of the Moscow Health Department", Moscow
"Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation (FSBEI HE Russian University of Medicine of the Ministry of Health of Russia)", Moscow
"State budgetary healthcare institution of the Moscow region Moscow Regional Research Clinical Institute named after M.F. Vladimirsky", Moscow
"Limited Liability Company Family Clinic No. 4", Korolyov
"Limited Liability Company Available Polyclinic", Murino
"Limited Liability Company Clinic of Skin Diseases Pierre Wolkenstein", Saint Petersburg
"Limited Liability Company International Medical Center", Saint Petersburg
"Limited Liability Company Medical Technologies LLC Medical Technologies", Saint Petersburg
"Limited Liability Company Health Energy", Saint Petersburg
"Limited Liability Company Interleukin", Saint Petersburg
"Limited Liability Company Institute of Medical Research", Saint Petersburg
"Limited Liability Company Research Center Eco-Safety", Saint Petersburg
"Limited Liability Company PiterKlinika", Saint Petersburg
"Limited Liability Company ArsVite North-West", Saint Petersburg
"Limited Liability Company Curator", Saint Petersburg
"Private medical institution Euromedservice", Saint Petersburg
"Limited Liability Company MEDINET", Saint Petersburg
"Regional state budgetary healthcare institution Smolensk Dermatovenerological Dispensary", Smolensk
"State budgetary institution of the Ryazan region Regional clinical dermatovenerological dispensary", Ryazan
"State health care institution Regional Dermatovenerological Dispensary", Lipetsk
"Limited Liability Company SB Clinic of Cosmetology", Saratov
"Limited Liability Company Medical Center Azbuka Health", Kazan'
"Limited Liability Company Alliance Biomedical - Ural Group", Izhevsk
State Budgetary Healthcare Institution Ulyanovsk area Clinical Hospital, Ulyanovsk
"State budgetary healthcare institution Chelyabinsk Regional Clinical Dermatovenerological Dispensary", Chelyabinsk
"Limited Liability Company Ecology of Health", Chelyabinsk
Federal State Budgetary Educational Institution of Higher Education Orenburg State Medical University of the Ministry of Health of Russia, Orenburg
"Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of the Russian Federation (FSBEI HE Kirov State Medical University of the Ministry of Health of Russia))", Kirov
"State budgetary institution of the Sverdlovsk region Ural Research Institute of Dermatovenereology and Immunopathology", Yekaterinburg
"Limited Liability Company Medical Center Healthy Family", Novosibirsk
"Federal State Budgetary Educational Institution of Higher Education Altai State Medical University of the Ministry of Health of the Russian Federation", Barnaul
AO GENERIUM
INDUSTRY